Understanding and targeting cancer stemness and immune suppression in advanced gastric cancer
Molecular dissecting and targeting YAP1 mediated cancer stemness and immune suppression in advanced gastric adenocarcinoma
This study is looking at how a protein called YAP1 affects advanced stomach cancer, especially in patients with cancer that has spread to the lining of the abdomen, to find new ways to treat this tough condition and help improve outcomes for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Coriell Institute for Medical Research NIH-funded |
| Lab location | 1 site (Camden, United States) |
| Project ID | NIH-10933008 on NIH RePORTER |
What this research studies
This research investigates the role of YAP1 in advanced gastric adenocarcinoma, particularly focusing on its impact on cancer stemness and immune suppression in patients with peritoneal carcinomatosis. By analyzing patient-derived specimens, the study aims to uncover the molecular mechanisms that contribute to the aggressive nature of this cancer and its resistance to treatment. The researchers will utilize advanced techniques, including single-cell RNA sequencing, to identify potential therapeutic targets that could improve patient outcomes. The ultimate goal is to develop novel treatments that can effectively combat this challenging condition.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with advanced gastric adenocarcinoma, particularly those experiencing peritoneal carcinomatosis.
Not a fit: Patients with early-stage gastric cancer or those without peritoneal carcinomatosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that significantly improve survival rates and quality of life for patients with advanced gastric adenocarcinoma.
How similar studies have performed: While the specific approach of targeting YAP1 in this context is novel, similar research has shown promise in other cancer types, indicating potential for success.
Where this research is happening
Camden, United States
- Coriell Institute for Medical Research — Camden, United States (Active)
Researchers
- Principal investigator: Song, Shumei — Coriell Institute for Medical Research
- Study coordinator: Song, Shumei
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.